Klebsiella pneumoniae is among the most common antibiotic-resistant pathogens causing
nosocomial infections. Additionally, it is a leading cause of neonatal sepsis and childhood …

ABSTRACT K1/K2 hvKP strains acquire carbapenem-resistance plasmids, known as CR-
hvKp, and carbapenem-resistant Klebsiella pneumoniae (CRKP) strains obtain virulence …

Klebsiella pneumonia e (K. pneumoniae) is a typical gram-negative iatrogenic bacterium
that often causes bacteremia, pneumonia and urinary tract infection particularly among …

The present study describes the design and fabrication of a novel vaccine candidate based
on the outer membrane protein A (rOmpA) from Klebsiella pneumoniae (K. pneumoniae) …

Background Klebsiella pneumoniae liver abscess (KPLA) with extrahepatic migratory
infections is defined as invasive KPLA (IKPLA). The type VI secretion system (T6SS) is …

Klebsiella pneumoniae causes community-and healthcare-associated infections in children
and adults. Globally in 2019, an estimated 1.27 million (95% Uncertainty Interval [UI]: 0.91 …

Treatment of Klebsiella pneumoniae causing pyogenic infections is challenging. The clinical
and molecular characteristics of Klebsiella pneumoniae causing pyogenic infections are …

Antimicrobial resistance (AMR) is considered by WHO one of the top ten public health
threats. New control strategies involving concerted actions of both public and private sectors …

This study presents the design and fabrication of an innovative vaccine candidate targeting
Pseudomonas aeruginosa (P. aeruginosa). The vaccine consists of gelatin nanoparticles …

The development of a whole-cell vaccine from bacteria auxotrophic for D-amino acids
present in the bacterial cell wall is considered a promising strategy for providing protection …